DBVT and DBV Related Headlines

Go Back

Jan 16, 2026 06:11PM DBV Technologies Announces €166.7 Million in Gross Proceeds Following the Full Exercise of the ABSA Warrants and BS Warrants Issued on its March 2025 Financing
Jan 5, 2026 04:00PM Information Regarding the Total Number of Voting Rights and Total Number of Shares of the Company as of December 31, 2025
Nov 11, 2025 11:50PM DBV Technologies completes last patient visit in peanut patch trial
Nov 11, 2025 11:50PM DBV Technologies Announces Last Patient Visit Completed in VITESSE Phase 3 Clinical Trial of VIASKIN® Peanut Patch in Peanut Allergic Children Aged 4-7 Years
Oct 29, 2025 06:47PM DBV Technologies Announces Sale of approximately $30 million of ADSs Through its At-The-Market (ATM) Program on Nasdaq
Oct 6, 2025 05:02PM DBV Technologies Announces Sale of approximately $30 million of ADSs Through its At-The-Market (ATM) Program on Nasdaq
Aug 1, 2025 04:05PM Information regarding the total number of voting rights and total number of shares of the Company as of July 31, 2025
Jul 29, 2025 04:17PM DBV Technologies announces filing of 2025 Half-Year Report ― Conditions for accessing or consulting the Report
Jul 29, 2025 04:08PM DBV Technologies Reports Second Quarter and Half-Year 2025 Financial Results

DBVT and DBV Related Press Releases

Go Back

Jan 16, 2026 06:11PM DBV Technologies Announces €166.7 Million in Gross Proceeds Following the Full Exercise of the ABSA Warrants and BS Warrants Issued on its March 2025 Financing
Jan 5, 2026 04:00PM Information Regarding the Total Number of Voting Rights and Total Number of Shares of the Company as of December 31, 2025
Nov 11, 2025 11:50PM DBV Technologies Announces Last Patient Visit Completed in VITESSE Phase 3 Clinical Trial of VIASKIN® Peanut Patch in Peanut Allergic Children Aged 4-7 Years
Oct 29, 2025 06:47PM DBV Technologies Announces Sale of approximately $30 million of ADSs Through its At-The-Market (ATM) Program on Nasdaq
Oct 6, 2025 05:02PM DBV Technologies Announces Sale of approximately $30 million of ADSs Through its At-The-Market (ATM) Program on Nasdaq
Aug 1, 2025 04:05PM Information regarding the total number of voting rights and total number of shares of the Company as of July 31, 2025
Jul 29, 2025 04:17PM DBV Technologies announces filing of 2025 Half-Year Report ― Conditions for accessing or consulting the Report
Jul 29, 2025 04:08PM DBV Technologies Reports Second Quarter and Half-Year 2025 Financial Results

DBVT and DBV Related SEC Filings

Go Back

Mar 2, 2026 07:54AM Form 8-K DBV Technologies S.A. For: Feb 28
Feb 17, 2026 06:08PM Form SCHEDULE 13G/A DBV Technologies S.A. Filed by: Venrock Healthcare Capital Partners II, L.P.
Feb 17, 2026 04:38PM Form SCHEDULE 13G/A DBV Technologies S.A. Filed by: CITADEL ADVISORS LLC
Feb 17, 2026 04:12PM Form SCHEDULE 13G DBV Technologies S.A. Filed by: MPM BioImpact LLC
Feb 17, 2026 04:12PM Form SCHEDULE 13G DBV Technologies S.A. Filed by: MPM BioImpact LLC
Feb 13, 2026 06:12PM Form SCHEDULE 13G/A DBV Technologies S.A. Filed by: Vivo Opportunity Fund Holdings, L.P.
Feb 13, 2026 11:25AM Form SCHEDULE 13G/A DBV Technologies S.A. Filed by: Invus Global Management, LLC
Feb 3, 2026 02:00PM Form SCHEDULE 13G DBV Technologies S.A. Filed by: Artisan Partners Limited Partnership
Feb 2, 2026 04:30PM Form 4 DBV Technologies S.A. For: Jan 29 Filed by: Mohideen Pharis
Jan 20, 2026 06:02AM Form 8-K DBV Technologies S.A. For: Jan 16
Jan 14, 2026 05:36PM Form SCHEDULE 13D/A DBV Technologies S.A. Filed by: BAKER BROS. ADVISORS LP
Jan 14, 2026 04:33PM Form 4 DBV Technologies S.A. For: Jan 12 Filed by: 667, L.P.
Jan 8, 2026 12:16PM Form SCHEDULE 13G/A DBV Technologies S.A. Filed by: JANUS HENDERSON GROUP PLC
Jan 7, 2026 04:01PM Form SCHEDULE 13D/A DBV Technologies S.A. Filed by: Bpifrance Participations SA
Jan 5, 2026 04:02PM Form SCHEDULE 13D/A DBV Technologies S.A. Filed by: Bpifrance Participations SA
Dec 19, 2025 06:33PM Form SCHEDULE 13D/A DBV Technologies S.A. Filed by: Bpifrance Participations SA
Dec 19, 2025 04:04PM Form 4 DBV Technologies S.A. For: Dec 17 Filed by: Bpifrance SA
Dec 16, 2025 04:21PM Form 8-K DBV Technologies S.A. For: Dec 16
Dec 12, 2025 01:07PM Form SCHEDULE 13G/A DBV Technologies S.A. Filed by: JANUS HENDERSON GROUP PLC
Dec 8, 2025 11:45AM Form SCHEDULE 13G DBV Technologies S.A. Filed by: JANUS HENDERSON GROUP PLC
Nov 25, 2025 04:15PM Form 4 DBV Technologies S.A. For: Nov 20 Filed by: Mohideen Pharis
Nov 24, 2025 07:05PM Form 4 DBV Technologies S.A. For: Nov 21 Filed by: Tasse Daniel
Nov 24, 2025 07:05PM Form 4 DBV Technologies S.A. For: Nov 21 Filed by: Trapp Kevin Michael
Nov 24, 2025 07:05PM Form 4 DBV Technologies S.A. For: Nov 21 Filed by: Boucinha Virginie
Nov 14, 2025 05:41PM Form SCHEDULE 13G/A DBV Technologies S.A. Filed by: Venrock Healthcare Capital Partners II, L.P.
Nov 12, 2025 05:00PM Form 3 DBV Technologies S.A. For: Nov 03 Filed by: Trapp Kevin Michael
Nov 4, 2025 04:15PM Form SCHEDULE 13D/A DBV Technologies S.A. Filed by: Bpifrance Participations SA
Oct 30, 2025 04:50PM Form 8-K DBV Technologies S.A. For: Oct 30
Oct 29, 2025 06:01AM Form 8-K DBV Technologies S.A. For: Oct 28
Oct 28, 2025 04:44PM Form 10-Q DBV Technologies S.A. For: Sep 30
Oct 14, 2025 05:14PM Form SCHEDULE 13G DBV Technologies S.A. Filed by: Invus Global Management, LLC
Sep 18, 2025 04:43PM Form 8-K DBV Technologies S.A. For: Sep 18
Sep 5, 2025 04:38PM Form 8-K DBV Technologies S.A. For: Sep 05
Sep 5, 2025 04:06PM Form 424B5 DBV Technologies S.A.
Aug 14, 2025 06:02PM Form SCHEDULE 13G/A DBV Technologies S.A. Filed by: Venrock Healthcare Capital Partners II, L.P.
Aug 12, 2025 09:06AM Form SCHEDULE 13G DBV Technologies S.A. Filed by: Adage Capital Management, L.P.
Jul 31, 2025 04:15PM Form 4 DBV Technologies S.A. For: Jul 29 Filed by: Mohideen Pharis
Jul 29, 2025 05:28PM Form 8-K DBV Technologies S.A. For: Jul 29
Jul 29, 2025 04:02PM Form 10-Q DBV Technologies S.A. For: Jun 30
Jun 25, 2025 04:32PM Form 8-K DBV Technologies S.A. For: Jun 25
Jun 24, 2025 04:06PM Form S-8 DBV Technologies S.A.